May 22, 2022
1 min read
Save
8 important updates for Brain Cancer Awareness Month
May is Brain Cancer Awareness Month.
In conjunction with the observance, Healio provides the following updates on neuro-oncology research and treatment advances.
- Younger patients with diffuse midline glioma experienced prolonged clinical improvement after receiving an investigational chimeric antigen receptor T-cell therapy. Read more.
- Surgeons at Lenox Hill Hospital are recruiting patients for a first-in-human clinical trial to investigate the safety and feasibility of using belly fat to treat recurrent glioblastoma. Read more.
- A personalized cancer vaccine conferred a PFS benefit to a subset of patients with newly diagnosed glioblastoma. Read more.
- A retrospective observational study provided new insights into end-of-life care experiences for patients with intracranial high-grade gliomas. Read more.
- Patients with isocitrate dehydrogenase wild-type glioblastoma who used levetiracetam for the duration of chemoradiation may achieve longer OS. Read more.
- Results of early clinical trials suggest that chimeric antigen receptor T cells can be adapted successfully to target brain tumors. Read more.
- The FDA awarded 11 grants worth more than $25 million to fund clinical trials of medical products intended to treat patients with rare diseases. The grants provide funding for three studies of brain cancer treatments. Read more.
- In this version of Point/Counter, two clinicians debate whether proton therapy has a role in the treatment of brain tumors. Read more.